About Thunder Biotech
Thunder Biotech is a private company based in Provo, Utah. It has reported $24,514,789 raised in seven offerings on Form D since May 2017. Its chief executive is Jeff Hone.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 9, 2024 | Feb 26, 2024 | $100,000of $2.5M target | 2 | $50,000 | DebtRule 506(b) | Form D ↗ |
| Sep 16, 2022 | Oct 14, 2022amended Oct 17, 2022 | $1,000,000of $20.0M target | 1 | $1.0M | DebtRule 506(b) | Form D/A ↗2 earlier filings |
| Nov 30, 2021 | Oct 11, 2022 | $4,020,000of $15.0M target | 14 | $287K | EquityRule 506(b) | Form D ↗ |
| Oct 5, 2020 | Aug 22, 2022 | $8,320,515of $10.0M target | 40 | $208K | EquityRule 506(b) | Form D ↗ |
| Sep 30, 2019 | Aug 22, 2022 | $9,979,274of $10.0M target | 52 | $191K | EquityRule 506(b) | Form D ↗ |
| Oct 5, 2017 | Nov 6, 2017 | $325,000of $18.0M target | 3 | $108K | DebtRule 506(b) | Form D ↗ |
| Jan 30, 2017 | May 23, 2017 | $770,000of $2.0M target | 10 | $77,000 | EquityRule 506(b) | Form D ↗ |
| Total, seven offerings | $24,514,789 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Thunder Biotech's Form D filed Feb 26, 2024.
Earlier filings also listed Robert Mooney (executive officer and director, last listed Oct 2022), Morris Linton (executive officer, last listed Oct 2022), J. Antonelli (director, last listed Oct 2022), D. Israelsen (executive officer and director, last listed Oct 2022) and D. Schulthess (executive officer, director and promoter, last listed Nov 2017).